ARA-290 is a peptide that is derived from Erythropoietin (EPO). EPO has been utilized for decades because of its ability to stimulate red blood cell production within bone marrow. It can also alter a patient’s blood pressure, promote cell survival, and create a neuroprotective effect.

While ARA-290 does not stimulate red blood cell production, it may offer pain-relieving and neuroprotective effects. The full scope of ARA-290’s benefits is still being researched; however, it has the potential to decrease inflammatory pathways through a process known as paracrine signaling. It has also been linked to reduced HbA1c and improved cholesterol numbers. One of the most appealing possibility for ARA-290 is that it may have the ability to reduce neuropathic pain and stimulate natural wound repair processes.